CHIRP Program
MNCM Status Page
PIPE Medical Groups Resources
PIPE Medical Group Onboarding
PIPE Medical Group Guides & Specs
PIPE Medical Group Videos
PIPE Medical Group FAQ
PIPE Payer Resources
PIPE Payer Onboarding
PIPE Payer Guides & File Field Specifications
PIPE Payer FAQ
Registration & Portal Maintenance
Clinic and Provider Registration (Resources)
Clinic and Provider Registration (FAQs)
Technical, Submission & Validation Support
Technical Questions
Statewide Results
Preliminary Clinical Quality Measure Results
Preliminary HEDIS Performance Results
Final Clinical Quality Measure Results
Measure Questions
Adolescent Mental Health /Depression Screening
Asthma
Colorectal Cancer Screening
Depression
Diabetes & Vascular
General Measure Question
HEDIS Questions
Insurance and RELC supplemental data
Orthopedic Measures
Oncology Measures
Updates and Measure Changes
Clinical Measure Updates
Survey Questions
HIT Survey Questions
Special Projects
MNCM Webinar Series
Minnesota Care Coordination Effectiveness Study (MNCARES)
Security
Security Policies

Is Repatha an allowable substitution for a Statin Medication?

Creation date: 2/6/2019 1:09 PM Updated: 10/5/2021 3:13 PM diabetes exception medication odc ovc repatha repatha (evolocumab) statin vascular

Repatha (evolocumab) is not a statin but some patients may use it along with a statin when their LDL remains high. If a patient is taking Repatha along with a statin, then the statin medication counts for the statin component. However, Repatha (evolocumab) alone does not count for the statin medication or exception.

This category is for questions related to the Optimal Diabetes Care and the Optimal Vascular Care clinical quality measures.

Is Repatha an allowable substitution for a Statin Medication?

Contents